Diabetes Surgery Studied As Potential Treatment For Type 2
Links shared publicly online about this topic.
- 399total visits
Diabetes Surgery Studied As Potential Treatment For Type 2
View full resource at medicalnewstoday.com
Tags: Diabetes, Type 2 Diabetes, Healthy Living, Physician, Surgery, Science
Most Recently Shared on March 31, 2011 at 7:55 pm By:
Diabetes Surgery Studied As Potential Treatment For Type 2: Physicians at The University of Texas Health Science... http://bit.ly/e6e7pK
Surgery Works Better Than Drugs at Blood Sugar Control in Obese Patients - Diabetes Health
diabeteshealth.com — “Diabetes Health - Complications & Care: A1C. An Ohio-based study of overweight and obese type 2 patients shows that weight loss surgery works much better at controlling blood sugar levels than any known drug treatment.” View full resource at diabeteshealth.com
Most Recently Shared on April 2, 2012 at 6:57 pm By:
Surgery Works Better Than Drugs at Blood Sugar Control in Obese Patients http://t.co/jUnxmlZz
A.M. Vitals: A Boost for Surgery to Treat Diabetes - Health Blog - WSJ
blogs.wsj.com — “Here's what's making health news this morning:Boost for Surgery in Treating Diabetes (WSJ): Weight-loss surgery proved far more effective than medication in controlling blood sugar among obese patients in two new studies, strengthening the case that the stomach-shrinking procedures should be considered an important treatment option for Type 2 diabetes.” View full resource at blogs.wsj.com
Most Recently Shared on March 27, 2012 at 12:18 pm By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
A.M. Vitals: A Boost for Surgery to Treat Diabetes: Here’s what’s making health news this mor... http://t.co/IMHHLC9m @AlzheimersRead
Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes
eurekalert.org — “In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms standard medical treatment of severe type 2 diabetes.” View full resource at eurekalert.org
Most Recently Shared on March 26, 2012 at 6:27 pm By:
Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes: ( New York- Presbyterian Hosp... http://t.co/IxhzmgCb
Bariatric Surgery Dramatically Outperforms Standard Treatment for Type 2 Diabetes
newswise.com — “In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms standard medical treatment of severe type 2 diabetes.” View full resource at newswise.com
Most Recently Shared on March 26, 2012 at 4:42 pm By:
newswise Health Communicator and Health News
Bariatric Surgery Dramatically Outperforms Standard Treatment for Type 2 Diabetes http://t.co/3EmxFZj0
Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes
medicalxpress.com — “In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms standard medical treatment of severe type 2 diabetes.” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 4:35 pm By:
PhysOrg Health News Health News
Bariatric surgery dramatically outperforms standard treatment for type 2 diabetes http://t.co/XUfCcUDp
Bariatric Surgery Dramatically Outperforms Standard Treatment for Type 2 Diabetes
newswise.com — “In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery dramatically outperforms standard medical treatment of severe type 2 diabetes.” View full resource at newswise.com
Most Recently Shared on March 26, 2012 at 4:28 pm By:
#health news: Bariatric Surgery Dramatically Outperforms Standard Treatment for Type 2 Diabetes http://t.co/dXHyB8jH
BMC Clinical Pharmacology | Abstract | Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
biomedcentral.com — “Consistent with its effect on gastric emptying, exenatide, an injectable treatment for type 2 diabetes, may slow the absorption rate of concomitantly administered oral drugs resulting in a decrease in maximum concentration (Cmax). This study evaluated the drug interaction potential of exenatide when administered adjunctively with oral contraceptives, given their potential concomitant use.” View full resource at biomedcentral.com
Most Recently Shared on March 20, 2012 at 9:35 pm By:
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive http://t.co/NtAJ9ZIb
SLIMM T2D Study: Surgery of Lifestyle with Intensive Medical Management in the treatment of Type 2 Diabetes | Joslin Diabetes Center Blog
blog.joslin.org — “SLIMM T2D Study: Surgery of Lifestyle with Intensive Medical Management in the treatment of Type 2 Diabetes | Joslin Diabetes Center Blog” View full resource at blog.joslin.org
Most Recently Shared on January 12, 2012 at 9:39 pm By:
Joslin study on type 2 #diabetes treatment looking for participants: http://t.co/QIvoM8a5 #dsma #T2D
FDA guidance maps regulatory pathway for artificial pancreas - Related Stories - AdvaMed SmartBrief
smartbrief.com — “The FDA has unveiled draft guidance outlining the process for developing and seeking regulatory approval for artificial pancreas systems, a potential cutting-edge treatment for type 1 diabetes. The guidance aims to provide a clear pathway for the devices from clinical trials to outpatient studies t…” View full resource at smartbrief.com
Most Recently Shared on December 3, 2011 at 12:52 pm By:
#FDA guidance maps regulatory pathway for artificial pancreas http://t.co/ar2smJX9 #nurses #doctors
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment” View full resource at medpagetoday.com
Most Recently Shared on September 19, 2011 at 9:33 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - http://t.co/9D51Tv1U from @medpagetoday #health #medicine
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment” View full resource at medpagetoday.com
Most Recently Shared on September 17, 2011 at 6:02 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Gliptins show a 30% relative risk reduction of suffering a major cardiac event. http://t.co/LwJ12Qxu @diabetes
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 9:17 pm By:
EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers (CME/CE) http://t.co/wUsmdYno
Medical News: EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers - in Meeting Coverage, EASD from MedPage Today
medpagetoday.com — “LISBON -- While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment” View full resource at medpagetoday.com
Most Recently Shared on September 16, 2011 at 9:08 pm By:
EASD: 'Gliptin' Diabetes Drugs May Be Heart Savers (CME/CE): LISBON (MedPage Today) -- While… http://t.co/wjbooIio
Isis Initiates Phase 1 Study Of ISIS-PTP1BRx To Treat Type 2 Diabetes - QualityPoint Technologies
qualitypointtech.net — “Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is designed to increase the body's sensitivity to the natural hormone insulin, resulting in better glucose control for patients with type 2 diabetes. Because of its unique mechanism ISIS-PTP1BRx has the potential to contribute to the treatment of type 2 diabetes w” View full resource at qualitypointtech.net
Most Recently Shared on July 23, 2011 at 11:00 am By:
Isis Initiates Phase 1 Study Of ISIS-PTP1BRx To Treat Type 2 Diabetes: Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) a... http://bit.ly/pfR22g
IQWiG finds no differences between two treatment strategies for type 2 diabetes
news-medical.net — “Whether patients with type 2 diabetes mellitus benefit from attempts to lower their blood glucose levels to near-normal levels through treatment remains an unanswered question. The studies currently available provide indications of a benefit but also of potential harm.” View full resource at news-medical.net
Most Recently Shared on July 15, 2011 at 11:53 am By:
IQWiG finds no differences between two treatment strategies for type 2 diabetes: Whether patients with type 2 di... http://bit.ly/rjMdZE
Advertisement
